measles, vaccines, antibodies and big pharma money

Download Measles, Vaccines, Antibodies and Big Pharma Money

Post on 16-Jul-2015

200 views

Category:

Health & Medicine

0 download

Embed Size (px)

TRANSCRIPT

  • Vaccination is NOT Immunization Vran.orgVaclib.orgNVIC.orggreenmedinfo.comthinktwice.orgSanevax.orgvaccinationcouncil.orgvaccinetruth.orgdrsuzanne.netdrtenpenny.com"The great enemy of the truth is very often not the lie, deliberate, contrived and dishonest, but the myth, persistent, persuasive and unrealistic

  • Myths and DogmaVaccines are Safe and effective

    Vaccine preventable diseases

    Get vaccinated to protect those that cant have a vaccine

    Herd immunity

    Vaccines are the best way to protect your family

  • Individuals harmed by properly manufactured vaccines had few options for compensation before an court case in the 1950s

    In 1955 about 200 people were paralyzed and ten died after contracting polio from the Salk polio vaccinecertain lots of which contained virus that had not been inactivated in spite of manufacturers adherence to federal government standards.DPT LawsuitsThrough the 1970s and 1980sthe number of lawsuits brought against vaccine manufacturers increased dramatically, and manufacturers made large payouts to individuals and families claiming vaccine injury, particularly from the combined diphtheria-pertussis-tetanus (DPT) immunization.mounting legal fees, and large jury rewards, many pharmaceutical companies left the vaccine businessby the end of 1984, only one U.S. company still manufactured the DPT vaccineother vaccines were losing manufacturers as well.

  • Under the NVICP, those claiming a vaccine injury from a covered vaccine cannot sue a vaccine manufacturer without first filing a claim with the U.S. Court of Federal Claims

    The claim filer is reimbursed according to a formula, provided that all the medical records meet NCVIA standards and that review by the U.S. Department of Justice determines that all legal standards have been met.

    If a claim is denied, or if the claim is approved and the claimant rejects the compensation, only then may the claimant file a civil lawsuit.

    The National Childhood Vaccine Injury Act Reporting and Compensation Tables (VIT) list each covered vaccine, its associated adverse events, and the allowable interval from vaccination to onset of event.

    intussusseption within 30 days of receipt of oral, rhesus-based rotavirus vaccinebrachial neuritis within 0-28 days of receipt of tetanus toxoidanaphylaxis within 0-4 hours of receipt of a variety of vaccines, etc

  • it is estimated that only 1-10% of events are reported JAMA 1993

    Between mid-1999 & Jan. 4th 2004 there were 128,035 adverse reactions reported to VAERS this may represent between 1.28 million to 12.8 million of the actual vaccine associated adverse reactionsVAERs Vaccine Adverse Events Reporting System

  • U.S. Department of Health and Human Services published Statistics Reports period ending September 3, 2013 1989 to 20133,387 compensable claimsor money9,651 claims that were dismissed The U.S. Court of Federal Claims (aka the vaccine court) $2,569,336,538.59 for compensable claims $104,202,681.85 for attorneys feesattorneys fees for dismissed claims totaling $56,375,431.34$15,190,454.29 for interim attorneys fees the vaccines causing the most damage were: DPT 3,284; Influenza (Trivalent) 1,108; MMR 860; Hepatitis B 591; DtaP 353; OPV (Oral Polio) 280 The vaccine attributed to causing the most deaths was DTP with 696 deaths. 32 vaccines listed, very fewonly 5had no deaths attributed.

  • Federal Register, volume 49, Number 107 Friday 1 June, 1984, Rules and Regulations page 23007 which said: Any possible doubts, whether or not well founded, about the safety of the (polio) vaccine, cannot be allowed to exist in view of the need to assure that the vaccine will continue to be used to the maximum extent.

  • One strain came from lung cells taken from a female fetus of 3-months gestation, One strain from a male fetus at 14-weeks. One strain was used to make the rubella vaccine

    the fetuses were intentionally aborted, but were not aborted for the purpose of harvesting the cells. these cultures have been used to prepare hundreds of millions of doses of vaccines for rubella, hepatitis A, varicella, rabies, chicken pox vaccine

    The defense is that human cells are the best source for vaccines because cells taken from animals can carry animal viruses that would obviously be very harmful in any vaccine.

  • An additional increased spike in incidence of autism occurred in 1995 when the chicken pox vaccine was grown in human fetal tissue.Human. Fetal. Tissue.

    The National Network for Immunization Information reports that two different strains of human cell cultures made from fetuses have been used extensively in vaccine production for DECADES.

    Theoretical aspects of autism: Causes-A review Helen V. Ratajczak, Journal of Immunotoxicology, Vol. 8, No. 1, 2/9/11, informahealthcare.com Vaccines and autism: a new scientific review Sharyl Attkisson, CBS News, 3/31/11, cbsnews.com Human Fetal Links with Some Vaccines National Network for Immunization Information, 6/3/08, immunizationinfo.org

  • THE FUTURE OF MEASLES IN HIGHLY IMMUNIZED POPULATIONS A MODELING APPROACH

    American Journal of Epidemiology1984 Volume 120, Issue 1 Pp. 39-48. AbstractLittle is known about how an intensive measles elimination program changes the overall immune status of the population. A computer model was created to study the effect of the measles elimination program in the United States on the number of susceptibles in the population.

    the prevaccine era, approximately 10.6% of the population was susceptible to measles With the institution of the measles immunization program, the proportion of susceptibles in the population fell to 3.1% from 1978 through 1981 then began to rise by approximately 0.1% per year to reach about 10.9% in the year 2050.

  • THE FUTURE OF MEASLES IN HIGHLY IMMUNIZED POPULATIONS A MODELING APPROACHAmerican Journal of EpidemiologyVolume 120, Issue 1 Pp. 39-48. The susceptibles at this time were distributed evenly throughout all age groups. The model did not consider the potential effect of waning immunity. The results of this study suggest that measles elimination in the United States has been achieved by an effective immunization program aimed at young susceptibles combined with a highly, naturally immunized adult population. However, despite short-term success in eliminating the disease, long-range projections demonstrate that the proportion of susceptibles in the year 2050 may be greater than in the prevaccine era. Present vaccine technology and public health policy must be altered to deal with this eventuality.

  • Increased risk of non-influenza respiratory virus infections associated with receipt of inactivated influenza vaccineClin Infect Dis. 2012

    AbstractWe randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo.

    Over the following 9 months, TIV recipients had increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8).

    Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.

  • Implications of Vaccination and Waning Immunity, Proceedings of the Royal Society B, vol. 276, 2009J. M. Heffernan and M. J. Keeling When immunity wanes, vaccination has a far more limited impact on the average number of cases. While this observation has clear public-health implications, the dynamic consequences of the interaction between vaccination, waning immunity and boosting are far more striking.

    For high levels of vaccination (greater than 80%) and moderate levels of waning immunity (greater than 30 years), large-scale epidemic cycles can be induced.

  • While the role of antibodies in preventing virus infection and reinfection is unquestionable, their contribution to the resolution of viral disease is much more controversial.

    When humoral deficiencies, in particular Bruton's X-linked agammaglobulinemia (XLA) (8), were initially described, it was observed that bacterial infections rather than viral infections represented the main cause of morbidity and early mortality.

    On this basis it was proposed that humoral deficiencies could be seen as experiments of nature, demonstrating that antibodies play little or no role in controlling viral infections while they are crucial in the resolution of bacterial infections (discussed in reference 24). Such a view has acquired dogma status over the years and is commonly found in immunology textbooks and other scientific publications.Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene KnockoutsJ Virol. 2000 Nov; 74(21): 98139817.

  • While the role of antibodies in preventing virus infection and reinfection is unquestionable, their contribution to the resolution of viral disease is much more controversial.

    When humoral deficiencies, in particular Bruton's X-linked agammaglobulinemia (XLA) (8), were initially described, it was observed that bacterial infections rather than viral infections represented the main cause of morbidity and early mortality.

    On this basis it was proposed that humoral deficiencies could be seen as experiments of nature, demonstrating that antibodies play little or no role in controlling viral infections while they are crucial in the resolution of bacterial infections (discussed in reference 24). Such a view has acquired dogma status over the years and is commonly found in immunology textbooks and other scientific publications.Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene KnockoutsJ Virol. 2000 Nov; 74(21): 98139817.

    demonstrating that antibodies play little or no role in control

Recommended

View more >